GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells

European Journal of Human Genetics

Volumn 23, Issue 2, 2015, Pages 195-201

  Livide, Gabriella ^a   Patriarchi, Tommaso ^a,b   Amenduni, Mariangela ^a   Amabile, Sonia ^a   Yasui, Dag ^b   Calcagno, Eleonora ^c   Lo Rizzo, Caterina ^a   De Falco, Giulia ^a   Ulivieri, Cristina ^a   Ariani, Francesca ^a   Mari, Francesca ^a,d   Mencarelli, Maria Antonietta ^a,d   Hell, Johannes Wilhelm ^b   Renieri, Alessandra ^a,d   Meloni, Ilaria ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CDKL5 PROTEIN; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR D1; METHYL CPG BINDING PROTEIN 2; PROTEIN KINASE; UNCLASSIFIED DRUG; CDKL5 PROTEIN, HUMAN; GLUTAMATE RECEPTOR DELTA 1; MECP2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ALLELE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RETT SYNDROME; X CHROMOSOME INACTIVATION; CELL CULTURE; CYTOLOGY; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MUTATION; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT;

IPS;

CELLS, CULTURED; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; METHYL-CPG-BINDING PROTEIN 2; MUTATION; NEUROGENESIS; NEURONS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GLUTAMATE; RETT SYNDROME;

EID: 84921411214     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.81     Document Type: Article

References (71)

1. Rett A: Ueber ein eigenartiges hirnatrophisches Syndrom bei Hyperammonaemie im Kindesalter. Wien Med Wochenschrift 1966; 116: 723-726.
2. Chahrour M, Zoghbi HY: The story of Rett syndrome: from clinic to neurobiology. Neuron 2007; 56: 422-437.
3. Hagberg B, Aicardi J, Dias K, Ramos O: A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol 1983; 14: 471-479.
4. Williamson SL, Christodoulou J: Rett syndrome: new clinical and molecular insights. Eur J Hum Genet 2006; 14: 896-903.
5. Artuso R: Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria. Brain Dev 2010; 32: 17-24.
6. Neul J, Kaufmann W, Glaze D et al: Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010; 68: 944-950.
7. Amir RE, Zoghbi HY: Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Am J Med Genet 2000; 97: 147-152.
8. LaSalle JM, Goldstine J, Balmer D, Greco CM: Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet 2001; 10: 1729-1740.
9. Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY: Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 2002; 11: 115-124.
10. Jordan C, Li HH, Kwan HC, Francke U: Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet 2007; 8: 36.
11. Tudor M, Akbarian S, Chen RZ, Jaenisch R: Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci USA 2002; 99: 15536-15541.
12. Roux JC, Zala D, Panayotis N, Borges-Correia A, Saudou F, Villard L: Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway. Neurobiol Dis 2012; 45: 786-795.
13. Belichenko PV, Oldfors A, Hagberg B, Dahlstrom A: Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 1994; 5: 1509-1513.
14. Colantuoni C, Jeon OH, Hyder K et al: Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis 2001; 8: 847-865.
15. Blue ME, Naidu S, Johnston MV: Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 1999; 156: 345-352.
16. Johnston MV, Blue ME, Naidu S: Rett syndrome and neuronal development. J Child Neurol 2005; 20: 759-763.
17. Evans J, Archer H, Colley J et al: Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet 2005; 13: 1113-1120.
18. Scala E, Ariani F, Mari F et al: CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet 2005; 42: 103-107.
19. Montini E, Andolfi G, Caruso A et al: Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region. Genomics 1998; 51: 427-433.
20. Lin C, Franco B, Rosner MR: CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. Hum Mol Genet 2005; 14: 3775-3786.
21. Rusconi L, Salvatoni L, Giudici L et al: CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J Biol Chem 2008; 283: 30101-30111.
22. Rusconi L, Kilstrup-Nielsen C, Landsberger N: Extrasynaptic N-methyl-D-aspartate (NMDA) receptor stimulation induces cytoplasmic translocation of the CDKL5 kinase and its proteasomal degradation. J Biol Chem 2011; 286: 36550-36558.
23. Ricciardi S, Ungaro F, Hambrock M et al: CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. Nat Cell Biol 2012; 14: 911-923.
24. Kameshita I, Sekiguchi M, Hamasaki D et al: Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1. Biochem Biophys Res Commun 2008; 377: 1162-1167.
25. Nectoux J, Fichou Y, Rosas-Vargas H et al: Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes. J Cell Mol Med 2010; 14: 1962-1974.
26. Mari F, Azimonti S, Bertani I et al: CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 2005; 14: 1935-1946.
27. Bertani I, Rusconi L, Bolognese F et al: Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation. J Biol Chem 2006; 281: 32048-32056.
28. Carouge D, Host L, Aunis D, Zwiller J, Anglard P: CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol Dis 2010; 38: 414-424.
29. Takahashi K, Tanabe K, Ohnuki M et al: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
30. Lowry WE, Richter L: Signaling in adult stem cells. Front Biosci 2007; 12: 3911-3927.
31. Marchetto MC, Brennand KJ, Boyer LF, Gage FH: Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. Hum Mol Genet 2011; 20: R109-R115.
32. Urbach A, Bar-Nur O, Daley GQ, Benvenisty N: Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010; 6: 407-411.
33. Chamberlain SJ, Chen PF, Ng KY et al: Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci U S A 2010; 107: 17668-17673.
34. Marchetto MC, Carromeu C, Acab A et al: A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010; 143: 527-539.
35. Cheung AY, Horvath LM, Grafodatskaya D et al: Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet 2011; 20: 2103-2115.
36. Ananiev G, Williams EC, Li H, Chang Q: Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS One 2011; 6: e25255.
37. Amenduni M, De Filippis R, Cheung AY et al: iPS cells to model CDKL5-related disorders. Eur J Hum Genet 2011; 19: 1246-1255.
38. Hotta A, Cheung AY, Farra N et al: Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 2009; 6: 370-376.
39. Yuan SH, Martin J, Elia J et al: Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 2011; 6: e17540.
40. Safieddine S, Wenthold RJ: The glutamate receptor subunit delta1 is highly expressed in hair cells of the auditory and vestibular systems. J Neurosci 1997; 17: 7523-7531.
41. Yasui DH, Peddada S, Bieda MC et al: Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA 2007; 104: 19416-19421.
42. Pennartz S, Belvindrah R, Tomiuk S et al: Purification of neuronal precursors from the adult mouse brain: comprehensive gene expression analysis provides new insights into the control of cell migration, differentiation, and homeostasis. Mol Cell Neurosci 2004; 25: 692-706.
43. Chahrour M, Jung SY, Shaw C et al: MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008; 320: 1224-1229.
44. Chen Q, Zhu YC, Yu J et al: CDKL5, a protein associated with Rett syndrome, regulates neuronal morphogenesis via Rac1 signaling. J Neurosci 2010; 30: 12777-12786.
45. Ricciardi S, Kilstrup-Nielsen C, Bienvenu T, Jacquette A, Landsberger N, Broccoli V: CDKL5 influences RNA splicing activity by its association to the nuclear speckle molecular machinery. Hum Mol Genet 2009; 18: 4590-4602.
46. Nectoux J, Fichou Y, Cagnard N et al: Cell cloning-based transcriptome analysis in cyclin-dependent kinase-like 5 mutation patients with severe epileptic encephalopathy. J Mol Med (Berl) 2011; 89: 193-202.
47. Traynor J, Agarwal P, Lazzeroni L, Francke U: Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet 2002; 3: 12.
48. Yamazaki M, Araki K, Shibata A, Mishina M: Molecular cloning of a cDNA encoding a novel member of the mouse glutamate receptor channel family. Biochem Biophys Res Commun 1992; 183: 886-892.
49. Lomeli H, Sprengel R, Laurie DJ et al: The rat delta-1 and delta-2 subunits extend the excitatory amino acid receptor family. FEBS Lett 1993; 315: 318-322.
50. Mayat E, Petralia RS, Wang YX, Wenthold RJ: Immunoprecipitation, immunoblotting, and immunocytochemistry studies suggest that glutamate receptor delta subunits form novel postsynaptic receptor complexes. J Neurosci 1995; 15: 2533-2546.
51. Yasumura M, Yoshida T, Lee SJ, Uemura T, Joo JY, Mishina M: Glutamate receptor delta1 induces preferentially inhibitory presynaptic differentiation of cortical neurons by interacting with neurexins through cerebellin precursor protein subtypes. J Neurochem 2012; 121: 705-716.
52. Kuroyanagi T, Yokoyama M, Hirano T: Postsynaptic glutamate receptor delta family contributes to presynaptic terminal differentiation and establishment of synaptic transmission. Proc Natl Acad Sci USA 2009; 106: 4912-4916.
53. Ryu K, Yokoyama M, Yamashita M, Hirano T: Induction of excitatory and inhibitory presynaptic differentiation by GluD1. Biochem Biophys Res Commun 2012; 417: 157-161.
54. Belichenko PV, Wright EE, Belichenko NP et al: Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol 2009; 514: 240-258.
55. Chapleau CA, Calfa GD, Lane MC et al: Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol Dis 2009; 35: 219-233.
56. Chao HT, Zoghbi HY, Rosenmund C: MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007; 56: 58-65.
57. Gatto CL, Broadie K: Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci 2010; 2: 4.
58. Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, Nelson SB: Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 2005; 102: 12560-12565.
59. Medrihan L, Tantalaki E, Aramuni G et al: Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 2008; 99: 112-121.
60. Zhang ZW, Zak JD, Liu H: MeCP2 is required for normal development of GABAergic circuits in the thalamus. J Neurophysiol 2010; 103: 2470-2481.
61. Nguyen L, Rigo JM, Rocher V et al: Neurotransmitters as early signals for central nervous system development. Cell Tissue Res 2001; 305: 187-202.
62. Manent JB, Represa A: Neurotransmitters and brain maturation: early paracrine actions of GABA and glutamate modulate neuronal migration. Neuroscientist 2007; 13: 268-279.
63. Aronica E, Crino PB: Inflammation in epilepsy: clinical observations. Epilepsia 2011; 52(Suppl 3): 26-32.
64. Zweier C, de Jong EK, Zweier M et al: CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 2009; 85: 655-666.
65. Marangi G, Ricciardi S, Orteschi D et al: Proposal of a clinical score for the molecular test for Pitt-Hopkins syndrome. Am J Med Genet A 2012; 158A: 1604-1611.
66. Grillo E, Lo Rizzo C, Bianciardi L et al: Revealing the complexity of a monogenic disease: Rett syndrome exome sequencing. PLoS One 2013; 8: e56599.
67. Fallin MD, Lasseter VK, Avramopoulos D et al: Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 2005; 77: 918-936.
68. Glessner JT, Hakonarson H: Common variants in polygenic schizophrenia. Genome Biol 2009; 10: 236.
69. Guo SZ, Huang K, Shi YY et al: A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. Schizophr Res 2007; 93: 385-390.
70. Treutlein J, Muhleisen TW, Frank J et al: Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter. Schizophr Res 2009; 111: 123-130.
71. Yadav R, Gupta SC, Hillman BG, Bhatt JM, Stairs DJ, Dravid SM: Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors. PLoS One 2012; 7: e32969.